Chicago, IL – November 18, 2024 – Powerful Medical has been named the Best Science Pitch and Overall Winner at the prestigious American Heart Association (AHA) Health Tech Competition during the AHA 2024 Scientific Sessions held in Chicago, Illinois. This recognition underscores Powerful Medical’s leadership in innovative cardiovascular healthcare technology, with its flagship product, PMcardio, earning acclaim as a groundbreaking solution for diagnostics and care coordination.
The AHA Health Tech Competition celebrates revolutionary advancements in the prevention and treatment of cardiovascular diseases. In the final round, competing against four other health startups, Powerful Medical captivated a distinguished panel of judges—including top physicians, scientists, and industry leaders—with its compelling presentation of PMcardio.
PMcardio is a CE-certified Class IIb EU MDR medical device, trusted by over 60,000 clinicians, and capable of analyzing ECGs across 39 indications using AI trained on millions of outcomes. In just 18 months, the platform has screened more than 500,000 ECGs across 16 European markets, streamlining care coordination and significantly improving clinical outcomes.
“Winning this competition affirms the scientific rigor and clinical value of PMcardio,” said Dr. Robert Herman, Chief Medical Officer of Powerful Medical. “Our platform not only revolutionizes cardiovascular diagnostics but also empowers clinicians through our AI-augmented chest pain patient pathway. It is a critical step toward delivering equitable, efficient, and timely care for all patients, regardless of demographics. We’re proud to contribute to meaningful advancements in cardiology.”
The recognition at the AHA Health Tech Competition also coincides with Powerful Medical’s prominent presence at the AHA 2024 Scientific Sessions, where the company presented its latest advancements in AI-driven cardiovascular care:
- November 16: Gender disparities in cardiac care, presented by Dr. Timea Kisova
- November 16: AI-powered smartphone diagnostics, presented by Anthony Demolder, MD
- November 18: Cath lab activation solutions, presented by Dr. Robert Herman
- November 18: External validations of PMcardio (“Queen of Hearts”), presented by Dr. Samantha Harris (Washington University in St. Louis) and Dr. James Choi (Mount Sinai Morningside)
“We are honored to receive this recognition from the American Heart Association,” said Martin Herman, Co-Founder and CEO of Powerful Medical. “Winning both the Best Science Pitch and Overall Winner awards is a testament to the potential of PMcardio to transform cardiovascular care. This achievement is not just for our team, but for the thousands of clinicians and patients worldwide who benefit from our technology.”
The AHA Health Tech Competition’s rigorous two-pitch format evaluated companies on both scientific impact and business scalability. Powerful Medical impressed the judges with its demonstrated efficacy and a scalable business model addressing global cardiovascular challenges, including high rates of misdiagnosis and delayed treatment for heart attacks.
